Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discontinuation of Antiplatelet Agent After Drug-Coated Balloon Angioplasty in Stabilized Patients With High Bleeding Risk and Coronary Artery Disease

NCT06742931 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT06742931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06742931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discontinuation of Antiplatelet Agent After Drug-Coated Balloon Angioplasty in Stabilized Patients With High Bleeding Risk and Coronary Artery Disease
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
April 7, 2025
Completion date
December 31, 2031
Enrollment
1,200 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic coronary syndrome